Physician profile
Jason Nolt
NPI 1972999621
$3,693.92
in general payments reported to CMS, 2019-2025
7 companies · $3,049 in 2025
The $3,049 reported for 2025 was more than what 89% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $65.14 · 2022: $232 · 2023: $155 · 2024: $193 · 2025: $3,049.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,786 · Travel and Lodging: $1,610.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,786.38 |
| Travel and Lodging | $1,610.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,924.61 | 2022-2025 | Triclip |
| Edwards Lifesciences Corporation | $869.74 | 2025 | Evoque |
| Abiomed | $330.55 | 2021-2025 | Impella |
| W. L. Gore & Associates, INC. | $267.57 | 2023-2024 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis |
| Becton, Dickinson and Company | $179.22 | 2025 | Hemosphere |
| Haemonetics Corporation | $72.70 | 2025 | Teg6s Hemostasis System |
| Merck Sharp & Dohme LLC | $49.53 | 2022-2025 | Bridion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Nolt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.